DementiaAD-EuroNCT00554047
Comparison of Effectiveness and Costs of Post-diagnosis Treatment in Dementia
A study testing Multidisciplinary Memory Clinic and General Practitioners in people with Dementia, run by Radboud University Medical Center at 9 sites in Netherlands.
Trial summary
In the Netherlands a rapidly increasing number of multidisciplinary memory clinics (MMC) currently diagnose 25% of the patients with dementia. Following the diagnostic work-up, MMCs are increasingly involved in post-diagnosis treatment and coordination of care, which probably is very important for patients and… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Dementia
- What is being tested?
- Multidisciplinary Memory Clinic and General Practitioners
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 220 participants
- Where
- 9 sitesNetherlands
- Study dates
- Dec 2007to Jul 2010
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- A patient with a new dementia diagnosis made at the MMC of the participating centre fulfilling DSM-IV-TR criteria with a CDR 0.5, 1 or 2
- Each patient has a caregiver
- Both patients and caregivers can provide informed consent for participation in the study
Who cannot join
- Life expectancy less than 1 year
- Living in a nursing home
- Already evaluated as being suitable for living in a nursing home
- Data collection impossible (e.g., due to severe visual/hearing/language impairment, mood disorder, or behavioral disturbances)
- The patient's general practitioner does not agree to participate
- Already participating in another study
Show all 13Show fewer
- The patient visits the MMC for a second opinion
- Travel distance between MMC and patient's living address more than 50 kilometers
- A definite indication for memory clinic follow up:
- A definite need for symptomatic drug treatment as judged by treating physician (e.g., Dementia with Lewy Bodies)
- A definite need for specialist guidance as judged by treating physician (e.g., Creutzfeldt-Jakob Disease, severe Frontotemporal Lobar Disease)
- A definite wish for symptomatic drug treatment by patient or caregiver
- A definite need for guidance from psychiatric services involved in the memory clinic
Trial locations and contacts
9 sites in 1 country.
9 sites in 1 country
Netherlands9 sites
VU Medical Center, Alzheimer Centre
Amsterdam
Alysis Zorgroep, Rijnstate Hospital, Department of Geriatrics
Arnhem
GGZ Oost Brabant, Department of Geriatrics
Boxmeer
Slingeland Hospital, Department of Geriatrics
Doetinchem
Hospital Gelderse Vallei, Department of Geriatrics
Ede
Catharina hospital, Department of Geriatrics
Eindhoven
Elkerliek Hospital, Department of Geriatrics
Helmond
University Hospital Maastricht, Alzheimer Centre
Maastricht
University Medical Centre St Radboud, Alzheimer Centre
Nijmegen
About this study
Official title: Effectiveness and Costs of Post-diagnosis Treatment in Dementia Coordinated by Multidisciplinary Memory Clinics in Comparison to Treatment Coordinated by General Practitioners
In the Netherlands a rapidly increasing number of multidisciplinary memory clinics (MMC) currently diagnose 25% of the patients with dementia. Following the diagnostic work-up, MMCs are increasingly involved in post-diagnosis treatment and coordination of care, which probably is very important for patients and caregivers, but also very time consuming and expensive. This study will focus on the important question whether this complex post-diagnosis treatment and care coordination, evaluated both on effectiveness and costs, should be carried out by MMCs (intervention) or by General Practitioners (GPs) (control) as pivot of delivery of health care for these patients.
Objectives: To determine MMCs' effectiveness and cost-effectiveness in post-diagnosis treatment and care-coordination for dementia-patients and their caregivers compared to the post-diagnosis treatment and care coordination by GPs.
Read more
Time schedule: 12 months for including patients and their caregivers and 12 months of follow-up.
Annex Study: Specifically for the Health Technology Assessment (HTA) methodology study the main study will be extended with some experimental proxy measurements and alternative measurement approaches.
The objective of this Annex-study is to explore the feasibility and validity of Health Related Quality of Life (HRQL) value measurement in dementia patients. And to study the characteristics of proxy rating in HRQL research in dementia and the suitability and validity of yielding HRQL measurements by proxy assessment. Furthermore to explore the validity, reliability, and feasibility of the EQ5D and EQ6D in dementia research (in patients and in/by proxies); response shift, and alternative (more simple) methods of HRQL measurement and validate the Dutch versions of the QOL-AD and the use of the CarerQol-7D in dementia research.
- Conditions
- Dementia
- Being tested
- Multidisciplinary Memory Clinic, General Practitioners
- Keywords
- Dementia, Caregivers, Costs and cost analysis, Multicenter study, Randomized controlled trial, Quality Adjusted Life Years, Quality of life, Technology assessment, biomedical; Methods
- Medical subject headings
- Dementia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Multidisciplinary Memory ClinicOther
Post-diagnosis treatment and coordination of care for patients with dementia and their informal caregivers delivered by Multidisciplinary Memory Clinics (MMCs)
General PractitionersOther
Post-diagnosis treatment and coordination of care for patients with dementia and their informal caregivers delivered by general practitioners
| Study group | Role | What they receive |
|---|---|---|
| 1 | Experimental | Multidisciplinary Memory Clinic Receives: Other: Multidisciplinary Memory Clinic |
| 2 | Active comparator | General practitioner Receives: Other: General Practitioners |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proxy-rated Health Related Quality of Life of the patient (cpQol-AD)
Measured: at 0, 6 and 12 months
Informal caregivers burden (Sense of competence (SCQ))
Measured: at 0, 6 and 12 months
Cost utility analysis (EQ 5D)
Measured: at 0, 6 and 12 months
Secondary outcomes (6)
Geriatric Depression Scale (GDS-15)
Measured: at 0, 6 and 12 months
Care-related quality of life of informal caregivers (CarerQol-7D + CarerQol-VAS)
Measured: at 0, 6 and 12 months
Quality of Live AD caregiver (cQoL-AD)
Measured: at 0, 6 and 12 months
Neuro Psychiatric Inventory (NPI-Q)
Measured: at 0, 6 and 12 months
Functional performance patient (IDDD)
Measured: at 0, 6 and 12 months
Patients rated Health Related Quality of Life (pQol-AD)
Measured: at 0, 6 and 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Nov 2007 (estimated)
- Study startDec 2007
- Study completionJul 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for DementiaStudies of the same condition, open and under way.
- More trials run by Radboud University Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 220 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Radboud University Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- ZonMw: The Netherlands Organisation for Health Research and Development, Netherlands Alzheimer Foundation, Amsterdam UMC, location VUmc, Maastricht University Medical Center, Karolinska Institutet, Stockholm Health Economics AB, Slingeland Hospital, Elkerliek Hospital, Ggz Oost Brabant, Rijnstate Hospital
- Investigators
- Prof. Dr. M. Olde Rikkert, MD PhD, Principal investigator, University Medical Centre St Radboud, Nijmegen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00554047
- Sponsor's protocol ID
- ADE 072510
- Other IDs
- ZonMw 80-007022-98-07703, ZonMw 945-07-7039
- Acronym
- AD-Euro
- Status last verified
- Aug 2010
- First submitted
- 5 Nov 2007
- Last updated
- 10 Jan 2011
- Results posted
- No
- Data monitoring committee
- No
Publications
Meeuwsen E, Melis R, van der Aa G, Goluke-Willemse G, de Leest B, van Raak F, Scholzel-Dorenbos C, Verheijen D, Verhey F, Visser M, Wolfs C, Adang E, Olde Rikkert M. Cost-effectiveness of one year dementia follow-up care by memory clinics or general practitioners: economic evaluation of a randomised controlled trial. PLoS One. 2013 Nov 25;8(11):e79797. doi: 10.1371/journal.pone.0079797. eCollection 2013.
PubMed 24282511Meeuwsen EJ, Melis RJ, Van Der Aa GC, Goluke-Willemse GA, De Leest BJ, Van Raak FH, Scholzel-Dorenbos CJ, Verheijen DC, Verhey FR, Visser MC, Wolfs CA, Adang EM, Olde Rikkert MG. Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial. BMJ. 2012 May 15;344:e3086. doi: 10.1136/bmj.e3086.
PubMed 22589500Meeuwsen EJ, German P, Melis RJ, Adang EM, Goluke-Willemse GA, Krabbe PF, de Leest BJ, van Raak FH, Scholzel-Dorenbos CJ, Visser MC, Wolfs CA, Vliek S, Rikkert MG. Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial. J Nutr Health Aging. 2009 Mar;13(3):242-8. doi: 10.1007/s12603-009-0066-1.
PubMed 19262961
Study at a glance
From the registry record, last updated by the sponsor on 10 Jan 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness and Costs of Post-diagnosis Treatment in Dementia Coordinated by Multidisciplinary Memory Clinics in Comparison to Treatment Coordinated by General Practitioners
- ClinicalTrials.gov ID
- NCT00554047
- Acronym / sponsor ID
- AD-Euro / ADE 072510
- Conditions
- Dementia
- Keywords
- Dementia, Caregivers, Costs and cost analysis, Multicenter study, Randomized controlled trial, Quality Adjusted Life Years, Quality of life, Technology assessment, biomedical; Methods
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 220 participants (estimated)
- Lead sponsor
- Radboud University Medical CenterUniversity, hospital or other
- Collaborators
- ZonMw: The Netherlands Organisation for Health Research and Development, Netherlands Alzheimer Foundation, Amsterdam UMC, location VUmc, Maastricht University Medical Center, Karolinska Institutet, Stockholm Health Economics AB, Slingeland Hospital, Elkerliek Hospital, Ggz Oost Brabant, Rijnstate Hospital
- Study start
- Dec 2007
- Study completion
- Jul 2010 (actual)
- First posted
- 6 Nov 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In the Netherlands a rapidly increasing number of multidisciplinary memory clinics (MMC) currently diagnose 25% of the patients with dementia. Following the diagnostic work-up, MMCs are increasingly involved in post-diagnosis treatment and coordination of care, which probably is very important for patients and caregivers, but also very time consuming and expensive. This study will focus on the important question whether this complex post-diagnosis treatment and care coordination, evaluated both on effectiveness and costs, should be carried out by MMCs (intervention) or by General Practitioners (GPs) (control) as pivot of delivery of health care for these patients.
Objectives: To determine MMCs' effectiveness and cost-effectiveness in post-diagnosis treatment and care-coordination for dementia-patients and their caregivers compared to the post-diagnosis treatment and care coordination by GPs.
Time schedule: 12 months for including patients and their caregivers and 12 months of follow-up.
Annex Study: Specifically for the Health Technology Assessment (HTA) methodology study the main study will be extended with some experimental proxy measurements and alternative measurement approaches.
The objective of this Annex-study is to explore the feasibility and validity of Health Related Quality of Life (HRQL) value measurement in dementia patients. And to study the characteristics of proxy rating in HRQL research in dementia and the suitability and validity of yielding HRQL measurements by proxy assessment. Furthermore to explore the validity, reliability, and feasibility of the EQ5D and EQ6D in dementia research (in patients and in/by proxies); response shift, and alternative (more simple) methods of HRQL measurement and validate the Dutch versions of the QOL-AD and the use of the CarerQol-7D in dementia research.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 1 | Experimental | Other: Multidisciplinary Memory ClinicMultidisciplinary Memory Clinic |
| 2 | Active comparator | Other: General PractitionersGeneral practitioner |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- A patient with a new dementia diagnosis made at the MMC of the participating centre fulfilling DSM-IV-TR criteria with a CDR 0.5, 1 or 2
- Each patient has a caregiver
- Both patients and caregivers can provide informed consent for participation in the study
Key exclusion criteria (13 listed)
- Life expectancy less than 1 year
- Living in a nursing home
- Already evaluated as being suitable for living in a nursing home
- Data collection impossible (e.g., due to severe visual/hearing/language impairment, mood disorder, or behavioral disturbances)
- The patient's general practitioner does not agree to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Multidisciplinary Memory ClinicPost-diagnosis treatment and coordination of care for patients with dementia and their informal caregivers delivered by Multidisciplinary Memory Clinics (MMCs) | Other | 1 |
| General PractitionersPost-diagnosis treatment and coordination of care for patients with dementia and their informal caregivers delivered by general practitioners | Other | 2 |
Primary outcome
Proxy-rated Health Related Quality of Life of the patient (cpQol-AD)
Time frame: at 0, 6 and 12 months
Informal caregivers burden (Sense of competence (SCQ))
Time frame: at 0, 6 and 12 months
Cost utility analysis (EQ 5D)
Time frame: at 0, 6 and 12 months
6 secondary outcomes
Geriatric Depression Scale (GDS-15)
Time frame: at 0, 6 and 12 months
Care-related quality of life of informal caregivers (CarerQol-7D + CarerQol-VAS)
Time frame: at 0, 6 and 12 months
Quality of Live AD caregiver (cQoL-AD)
Time frame: at 0, 6 and 12 months
Neuro Psychiatric Inventory (NPI-Q)
Time frame: at 0, 6 and 12 months
Functional performance patient (IDDD)
Time frame: at 0, 6 and 12 months
Patients rated Health Related Quality of Life (pQol-AD)
Time frame: at 0, 6 and 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jan 2011.
- Derived from this study: PubMed 24282511Meeuwsen E, Melis R, van der Aa G, Goluke-Willemse G, de Leest B, van Raak F, Scholzel-Dorenbos C, Verheijen D, Verhey F, Visser M, Wolfs C, Adang E, Olde Rikkert M. Cost-effectiveness of one year dementia follow-up care by memory clinics or general practitioners: economic evaluation of a randomised controlled trial. PLoS One. 2013 Nov 25;8(11):e79797. doi: 10.1371/journal.pone.0079797. eCollection 2013.
- Derived from this study: PubMed 22589500Meeuwsen EJ, Melis RJ, Van Der Aa GC, Goluke-Willemse GA, De Leest BJ, Van Raak FH, Scholzel-Dorenbos CJ, Verheijen DC, Verhey FR, Visser MC, Wolfs CA, Adang EM, Olde Rikkert MG. Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial. BMJ. 2012 May 15;344:e3086. doi: 10.1136/bmj.e3086.
- Derived from this study: PubMed 19262961Meeuwsen EJ, German P, Melis RJ, Adang EM, Goluke-Willemse GA, Krabbe PF, de Leest BJ, van Raak FH, Scholzel-Dorenbos CJ, Visser MC, Wolfs CA, Vliek S, Rikkert MG. Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial. J Nutr Health Aging. 2009 Mar;13(3):242-8. doi: 10.1007/s12603-009-0066-1.
Related trials for Dementia
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Prof. Dr. M. Olde Rikkert, MD PhD principal investigator
University Medical Centre St Radboud, Nijmegen
9 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Multidisciplinary Memory Clinic and General Practitioners in people with Dementia, run by Radboud University Medical Center at 9 sites in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Jan 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 9 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proxy-rated Health Related Quality of Life of the patient (cpQol-AD) (time frame: at 0, 6 and 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00554047, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2011.